Literature DB >> 12727348

Mucosally-derived HPV-40 can infect both human genital foreskin and cutaneous hand skin tissues grafted into athymic mice.

Audrey L Jenkins1, C Max Lang, Lynn R Budgeon, Nancy M Cladel, Cynthia A Reed, Danny R Welch, Neil D Christensen, Audrey J Jenkins.   

Abstract

HPV-40 is a rare HPV type that has been detected only in genital mucosal tissues. This HPV type is very closely related to HPV-7, which has a predominantly cutaneous tissue tropism. We have shown, previously, that an isolate of HPV-40 (described here as HPV-40(Hershey) or HPV-40(H)) productively infected genital tissues. In this study, HPV-40(H) was tested for productive infection of cutaneous tissue. Fetal hand skin fragments were incubated with infectious HPV-40(H) and implanted subrenally into athymic mice. After 120 days, xenografts showed morphological changes consistent with HPV-40(H) infection and were HPV-40 DNA in situ positive and capsid antigen positive. The results demonstrated that hand skin can support HPV-40(H) infection thereby indicating that this viral type has the capacity to infect both genital mucosal and cutaneous tissues.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12727348     DOI: 10.1016/s0168-1702(03)00071-6

Source DB:  PubMed          Journal:  Virus Res        ISSN: 0168-1702            Impact factor:   3.303


  2 in total

1.  A novel pre-clinical murine model to study the life cycle and progression of cervical and anal papillomavirus infections.

Authors:  Nancy M Cladel; Lynn R Budgeon; Karla K Balogh; Timothy K Cooper; Jiafen Hu; Neil D Christensen
Journal:  PLoS One       Date:  2015-03-24       Impact factor: 3.240

2.  Efficacy of RG1-VLP vaccination against infections with genital and cutaneous human papillomaviruses.

Authors:  Christina Schellenbacher; Kihyuck Kwak; Dieter Fink; Saeed Shafti-Keramat; Bettina Huber; Christoph Jindra; Helena Faust; Joakim Dillner; Richard B S Roden; Reinhard Kirnbauer
Journal:  J Invest Dermatol       Date:  2013-05-10       Impact factor: 8.551

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.